← back to search

Stacey J. Winham

North Carolina State University · US
🔎 Find collaborators in Reproductive Medicine · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Reproductive Medicine · Genetics
Research interest
Research interests include Ovarian cancer, Medicine, Biology, Oncology, Breast cancer, and Genetics.
h-index
citations
3,359
works
66
NIH funding
primary concept
email

Recent publications

Association of gene variant type and location with breast cancer risk in the general population
Annals of Oncology 2025cited by 7position: middledoi
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Gynecologic Oncology 2025cited by 2position: middledoi
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
The Breast 2025cited by 1position: middledoi
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer
European Journal of Human Genetics 2025cited by 1position: middledoi
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Clinical Cancer Research 2024cited by 12position: middledoi
Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk
Cancer Epidemiology Biomarkers & Prevention 2024cited by 7position: middledoi
Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis
Cancer Epidemiology Biomarkers & Prevention 2024cited by 7position: middledoi
Polygenic risk scores stratify breast cancer risk among women with benign breast disease
JNCI Journal of the National Cancer Institute 2024cited by 4position: middledoi
Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer
Journal of Clinical Oncology 2023cited by 36position: middledoi
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
The Journal of Pathology Clinical Research 2023cited by 26position: middledoi
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
medRxiv 2023cited by 5position: middledoi
Abstract 5241: Association of polygenic risk scores with breast cancer risk among women with benign breast disease
Cancer Research 2023cited by 1position: firstdoi
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Nature Genetics 2022cited by 109position: middledoi
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Clinical Cancer Research 2022cited by 99position: middledoi
Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies
Journal of Affective Disorders 2022cited by 21position: middledoi
The genetics of bipolar disorder with obesity and type 2 diabetes
Journal of Affective Disorders 2022cited by 21position: middledoi
A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women
Cancer Research Communications 2022cited by 14position: middledoi
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
Scientific Reports 2022cited by 6position: middledoi
Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits
Biological Psychiatry 2021cited by 85position: middledoi
Association of mammographic density measures and breast cancer “intrinsic” molecular subtypes
Breast Cancer Research and Treatment 2021cited by 25position: middledoi
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2021cited by 23position: middledoi
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
Human Genetics and Genomics Advances 2021cited by 17position: middledoi
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer
Cancer Epidemiology Biomarkers & Prevention 2021cited by 12position: middledoi
Genome-Wide Interaction Analysis of Menopausal Hormone Therapy Use and Breast Cancer Risk Among 62,370 Women
Research Square 2021cited by 1position: middledoi
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Apollo (University of Cambridge) 2021cited by 0position: middledoi
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Clinical Cancer Research 2020cited by 75position: middledoi
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
British Journal of Cancer 2020cited by 68position: middledoi
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer
Journal of Medical Genetics 2020cited by 58position: middledoi
Evaluation of LIBRA Software for Fully Automated Mammographic Density Assessment in Breast Cancer Risk Prediction
Radiology 2020cited by 52position: middledoi
Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation
Cancer Epidemiology Biomarkers & Prevention 2020cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Celine M. Vachon · Mayo Clinic8 papers (2017–2023)Kathleen R. Brandt · University of Oslo6 papers (2017–2023)Karla Kerlikowske · City College of San Francisco6 papers (2017–2023)Christopher G. Scott · Mayo Clinic in Florida6 papers (2017–2023)Matthew R. Jensen · University of Minnesota, Twin Cities5 papers (2017–2023) · 4 papers (2017–2023)Ellen L. Goode · Mayo Clinic4 papers (2013–2024) · 4 papers (2017–2023)John Shepherd · University of Toronto3 papers (2017–2021)Susan L. McElroy · Southwestern Medical Center3 papers (2018–2022)V. Shane Pankratz · University of New Mexico3 papers (2017–2021)Julie M. Cunningham · Mayo Clinic3 papers (2013–2024)Robert A. Vierkant · Mayo Clinic in Arizona3 papers (2013–2023) · 2 papers (2022–2022)Mark A. Frye · Salk Institute for Biological Studies2 papers (2022–2022)Amir Pasha Mahmoudzadeh · Shiraz University of Medical Sciences2 papers (2017–2018) · 2 papers (2017–2018)Serghei Malkov · University of California, San Francisco2 papers (2017–2018)Yanina Natanzon · Case Western Reserve University2 papers (2018–2018)Aimilia Gastounioti · California University of Pennsylvania2 papers (2018–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Reproductive Medicine · Genetics →